IP Library › Assignment 049195/0001
Patent Assignment
Reel/Frame 049195/0001

Change of Name

Recorded: 2019-05-16 Pages: 7
Assignor
Assignee
FRONTIER BIOTECHNOLOGIES INC.
5 QIANDE ROAD, HIGH-TECH PARK BUILDING 7, JIANGNING DISTRICT, NANJING, 211122, CHINA
Covered Properties (2)
Human Immunodeficiency Virus (Hiv) GP41 Peptide Derivatives with Enhanced Solubility and Antiviral Activity.
Patent: 7,575,750 →
Application: 10/667,966 →
Publication: US 2005/0089840
Method of Inhibiting Hiv-1 Replication by Administering Modified GP41 C34 Peptide Derivatives with Enhanced Pharmacological Properties
Patent: 8,470,527 →
Application: 12/567,250 →
Publication: US 2011/0003735
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 29, 2004
From: XIE, DONG; JIANG, HE
To: FRONTIER BIOTECHNOLOGIES CO., LTD.
Reel/Frame 015516/0286 →
Assignment of Assignor's Interest Jun 14, 2013
From: FRONTIER BIOTECHNOLOGIES CO., LTD.
To: BAOBAB PHARMACEUTICALS LIMITED
Reel/Frame 030611/0712 →
Assignment of Assignor's Interest Oct 25, 2013
From: BAOBAB PHARMACEUTICALS LIMITED
To: NANJING FRONTIER BIOTECHNOLOGIES CO., LTD.
Reel/Frame 031475/0613 →